#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fungal infection Chronic myeloid leukaemia (in remission) Mucopolysaccharidosis II Antisynthetase syndrome Bronchiectasis Hyperinsulinism Vulval cancer recurrent Arterial disorder Hodgkin's disease Congenital absence of bile ducts Fusarium infection Hypochromic anaemia Immune-mediated myositis Leukodystrophy Fatty acid oxidation disorder More trials…

    Learn about Rare Diseases

    Focal segmental glomerulosclerosis – Treatment Factor VIII deficiency – Life with Disease Angiosarcoma non-metastatic – Basic Information Pemphigoid – Basic Information Cholangitis sclerosing – Life with Disease Lymphangioma – Basic Information Combined immunodeficiency – Treatment Breast angiosarcoma metastatic – Trials in Disease Lymphangioma – Life with Disease Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Belzupacap Sarotalocan Fludeoxyglucose (18F) Abc-23A-116 Pancreas Powder Lauromacrogol 400 AP31969 SULFATE Corline Heparin Conjugate Stx-241 Sacubitril Valsartan Rbl005.3 ZOREVUNERSEN SODIUM [18F]Fluoro-Peg-Folate Larotrectinib Sulfate ALN-4324 Cladribine Cenegermin Tasquinimod Testosterone Lenzumestrocel Antithrombin Iii Human More therapies…

    Learn about Your Condition

    Herpes simplex meningitis Noonan syndrome Pre-eclampsia Hypertension Labour pain Biotinidase deficiency Acromegaly Hyperglycaemia Diabetic foot Obliterative bronchiolitis Guttate psoriasis Schizophrenia Blood disorder B-cell lymphoma Vulvovaginal pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Haemodialysis

  • A study comparing medium-chain triglycerides and sodium chloride infusions during hemodialysis to improve toxin removal in patients with chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Soya Oil
    • Triglycerides, Medium Chain
    • Sodium Chloride
    France

  • Study on Rivaroxaban for Patients with End-Stage Renal Disease on Hemodialysis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • Rivaroxaban
    France

  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    • Peritoneal dialysis
    • Atrial fibrillation
    Investigated Drugs:
    • Warfarin Sodium
    Denmark

  • Ketosteril Added to Usual Nutrition for Patients Starting Incremental Haemodialysis with Incremental Haemodialysis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • Alpha-Ketophenylalanine Calcium
    • Hydroxi-Methionine Calcium
    • Keto-Isoleucine Calcium
    France

  • Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • ARGININE GLUTAMATE
    • Aspartic Acid
    • Histidine Hydrochloride Monohydrate
    The Netherlands

  • Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Haemodialysis
    • Renal failure
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Austria
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!